Nina Bucalo (Author), Borut Jereb (Author)

Abstract

The pharmaceutical industry is one of the most competitive businesses in the world. Supply chain in this industry has been directed towards the production of large batches to avoid lack of supplies, and the achievement of regulatory requirements, at the cost of high level of inventory, higher costs and inventory write-off due to expiration or other reasons. In recent years this industry is facing major changes and challenges such as intense globalization processes, increased competition and innovations in technologies, which has broadened and deepened risks in supply chain. The paper reports the results of the study of the risk in distribution processes of Slovenian pharmaceutical companies, which was conducted among five companies and aims to draw attention to risks that arise in supply chain, to emphasize the importance of their management and to present a model for an effective assessment of risk in companies, developed at the Faculty of Logistics.

Keywords

upravljanje tveganj;katalog tveganj;proizvodna podjetja;farmacevtska industrija;distribucija;logistika;Slovenija;risk management;risk catalog;production companies;pharmaceutical industry;distribution;logistics;Slovenia;

Data

Language: English
Year of publishing:
Typology: 1.03 - Short Scientific Article
Organization: UM FL - Faculty of Logistics
UDC: 005.4
COBISS: 512846397 Link will open in a new window
ISSN: 2232-4968
Views: 863
Downloads: 403
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary language: Slovenian
Secondary keywords: upravljanje tveganj;katalog tveganj;proizvodna podjetja;farmacevtska industrija;distribucija;logistika;Slovenija;
URN: URN:SI:UM:
Type (COBISS): Scientific work
Pages: str. 42-49
Volume: ǂVol. ǂ8
Issue: ǂno. ǂ1
Chronology: May 2017
DOI: 10.1515/jlst-2017-0004
ID: 10847111